- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 14-03-2026: Press Release
14-03-2026 | 01:39 pm
14-03-2026 | 01:39 pm
Zydus's innovative drug, Desidustat (licensed to China Medical System), secured approval in China for renal anaemia in CKD patients. This oral treatment addresses a large unmet need, tapping into China's over 120 million CKD patient market.
No comments yet. Be the first to comment!